Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

4.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.4K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

802
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
802
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

731
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
731

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study].

Giornale italiano di cardiologia (2006)·2026
Same author

[Fish Oil for the Heart? The Role of Omega-3 Fatty Acids in Cardiovascular Medicine].

MMW Fortschritte der Medizin·2026
Same author

MMW Fortschritte der Medizin·2026
Same author

Lipid Therapy in Patients with Diabetes Mellitus.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

Association of the C-reactive protein-triglyceride glucose index with all-cause and cardiovascular mortality among U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cohort study.

Cardiovascular diabetology·2026
Same author

MMW Fortschritte der Medizin·2026

Related Experiment Video

Updated: Jun 29, 2025

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.0K

Differentiating EPA from EPA/DHA in cardiovascular risk reduction.

Peter P Toth1,2, M John Chapman3, Klaus G Parhofer4

  • 1CGH Medical Center, Sterling, IL, USA.

American Heart Journal Plus : Cardiology Research and Practice
|April 1, 2024
PubMed
Summary
This summary is machine-generated.

High-dose purified eicosapentaenoic acid (EPA) significantly reduced cardiovascular events and mortality in the REDUCE-IT trial, unlike other omega-3 fatty acid combinations. This highlights EPA

Keywords:
Cardiovascular diseasesDocosahexaenoic acidEicosapentaenoic acidIcosapent ethylOmega-3 fatty acidTriglyceride

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.3K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Related Experiment Videos

Last Updated: Jun 29, 2025

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.0K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.3K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Previous trials with combined eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) failed to demonstrate cardiovascular benefits, despite triglyceride reduction.
  • The distinct pharmacology of EPA versus DHA suggests different mechanisms of action on inflammation and cellular processes.

Purpose of the Study:

  • To evaluate the efficacy of high-dose purified EPA in reducing cardiovascular events in patients at risk.
  • To compare the cardiovascular outcomes of purified EPA with placebo in patients on statin therapy.

Main Methods:

  • The Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial (REDUCE-IT) administered high-dose (4 g/day) purified EPA.
  • Participants received EPA as adjuvant therapy to statin treatment.
  • Cardiovascular outcomes, including major adverse cardiovascular events and mortality, were compared between the EPA and placebo groups.

Main Results:

  • High-dose purified EPA demonstrated a 25% reduction in atherosclerotic cardiovascular disease-related events (HR 0.75; P < 0.001).
  • REDUCE-IT showed a significant reduction in cardiovascular mortality, a first for a lipid-lowering agent as adjuvant statin therapy.
  • Significant decreases in stroke, myocardial infarction, and the need for revascularization were observed.

Conclusions:

  • High-dose purified EPA is effective in reducing cardiovascular events and mortality in specific patient populations, particularly when used with statins.
  • Attained plasma EPA levels, potentially above 100 μg/mL, may be crucial for achieving clinical benefit.
  • The findings affirm the efficacy of EPA therapy for cardiovascular disease risk reduction, distinct from combined EPA and DHA formulations.